Cassava Sciences
About:
Cassava Sciences is a clinical-stage biopharmaceutical company focused on neuroscience.
Website: https://www.cassavasciences.com/
Top Investors: National Institutes of Health
Description:
Cassava Sciences is a clinical-stage biopharmaceutical company focused on neuroscience. We translate novel scientific insights into new medicines. That’s a drastic challenge. Our work is complex, risky, labor-intensive, persistent and expensive.
Total Funding Amount:
$257M
Estimated Revenue Range:
$100M to $500M
Headquarters Location:
Austin, Texas, United States
Founded Date:
1998-01-01
Founders:
Remi Barbier
Number of Employees:
11-50
Last Funding Date:
2022-11-18
IPO Status:
Public
Industries:
© 2025 bioDAO.ai